The present invention relates to the use of vaccine formulations comprising cleaved envelope virus preparations but not split influenza virus formulations for the manufacture of a vaccine formulation suitable for intranasal administration. The invention further relates to methods of making such formulations and to the use of such vaccines for the prevention or treatment of disease. SHE
展开▼